A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Clinical trial NCT03752398 · COMPLETED

Trial details

NCT number: NCT03752398
Sponsor: Xencor, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Excluding Uveal Melanoma)Cervical Carcinoma Pancreatic Carcinoma Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative Hepatocellular Carcinoma Urothelial Carcinoma Squamous Cell Carcinoma of the Head and Neck Nasopharyngeal Carcinoma Renal Cell Carcinoma Colorectal Carcinoma Endometrial Carcinoma Non-small Cell Lung Carcinoma

Start date: 2019-05-01
Primary completion: 2024-02-15
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.